Kelly Jameson, PhD

The David Geffen School of Medicine at UCLA
Back to Team

Kelly Jameson serves as Manager on the TMC Strategy and New Ventures team, where she leads investment diligence for the TMC Venture Fund, focusing on therapeutics and medical devices. She has spearheaded investments across a range of novel biotech and medtech innovations and has supported diligence across the fund’s broader healthcare portfolio.

Kelly holds a Ph.D. in Neuroscience from UCLA, where she researched microbiome-nervous system interactions, and a Bachelor of Science in Neuroscience from the University of Texas at Austin. Her multidisciplinary scientific background informs her approach to evaluating early-stage medical technologies and assessing their commercial potential.

In addition to venture fund work, Kelly supports strategic initiatives across TMC’s core business portfolio and partner engagements.